Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA
Clinical trial NCT05769478 · COMPLETED
Trial details
- NCT number
- NCT05769478
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2024-10-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.